Drug profile · INN
canagliflozin
INVOKANA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
canagliflozin (INVOKANA) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN canagliflozin
Brand INVOKANA
Route ORAL
Formulation TABLET, EXTENDED RELEASE
ATC code A10BK02
Originator Teva Pharma GmbH
Frequently asked questions
What is canagliflozin?
canagliflozin (INVOKANA) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for canagliflozin?
INVOKANA is a marketed brand name for canagliflozin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of canagliflozin?
canagliflozin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.